Form 4: Syra Health Corp Director Acquires Stock Options
SEC Form 4
A Syra Health Corp director, Vijayapal Reddy, acquired 15,442 stock options at an exercise price of $0.3683 on November 14, 2024.
Summary
- On November 14, 2024, Vijayapal Reddy, a director at Syra Health Corp, acquired 15,442 stock options.
- The exercise price for these options is $0.3683 per share.
- The options were granted under the company's 2022 Omnibus Equity Incentive Plan.
- 25% of the options vested immediately, and the remaining options will vest in 12 equal monthly installments.
- The options expire on November 14, 2034.
Sentiment
Score: 7
Explanation: The document reflects a standard insider transaction, which is generally positive as it aligns director interests with the company's performance. The vesting schedule is also a positive sign.
Positives
- The acquisition of stock options by a director may indicate confidence in the company's future performance.
- The vesting schedule incentivizes the director to remain with the company and contribute to its success.
Risks
- The exercise of these options could potentially dilute existing shareholders' equity if the options are exercised.
Future Outlook
The vesting schedule of the options suggests a long-term incentive for the director.
Industry Context
Stock option grants are a common practice for incentivizing directors and key personnel in publicly traded companies.
Comparison to Industry Standards
- Stock option grants are a standard form of compensation for directors in publicly listed companies.
- The vesting schedule of 25% immediately and the remainder over 12 months is a common practice to align director interests with shareholder value creation.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive sign of management's commitment to the company.
- The vesting schedule may encourage the director to focus on long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 11/14/2024 | Date of the stock option grant and initial vesting. |
| 11/18/2024 | Date the Form 4 was signed. |
| 11/14/2034 | Expiration date of the stock options. |
Keywords
stock options, insider trading, equity incentive plan, director, Syra Health Corp, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.